Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Protein Engineering|June 27, 2003
Insight into the mechanism of the IMP-1 metallo-beta-lactamase by molecular dynamics simulationsPeter Oelschlaeger, Rolf D Schmid, Jürgen Pleiss
Protein Science : a Publication of the Protein Society|February 22, 2005
Impact of remote mutations on metallo-beta-lactamase substrate specificity: implications for the evolution of antibiotic resistancePeter Oelschlaeger, Stephen L Mayo, Juergen Pleiss
Antimicrobial Agents and Chemotherapy|September 26, 2012
The sequence-activity relationship between metallo-β-lactamases IMP-1, IMP-6, and IMP-25 suggests an evolutionary adaptation to meropenem exposureEleanor M Liu, Kevin M Pegg, Peter Oelschlaeger
Microbiology Spectrum|November 18, 2025
Impact of synonymous mutations in the blaTEM-3 gene on gene expression and Escherichia coli fitnessRinku Dhungana, Heba Kaadan, Aparna Paudel, et al.
Advances in Pharmacology (San Diego, Calif.)|June 6, 2022
Polymorphisms in common antihypertensive targets: Pharmacogenomic implications for the treatment of cardiovascular diseaseDominique Brown, Heather Alcala, Peter Oelschlaeger, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
Azolylthioacetamide: A Highly Promising Scaffold for the Development of Metallo-β-lactamase InhibitorsShao-Kang Yang, Joon S Kang, Peter Oelschlaeger, et al.
Plos One|July 3, 2015
Uncovering Molecular Bases Underlying Bone Morphogenetic Protein Receptor Inhibitor SelectivityAbdelaziz Alsamarah, Alecander E LaCuran, Peter Oelschlaeger, et al.
Protein Engineering, Design & Selection : PEDS|April 12, 2005
Computationally designed variants of Escherichia coli chorismate mutase show altered catalytic activityJonathan Kyle Lassila, Jennifer R Keeffe, Peter Oelschlaeger, et al.
Biochemistry|June 7, 2006
Simulating the effect of DNA polymerase mutations on transition-state energetics and fidelity: evaluating amino acid group contribution and allosteric coupling for ionized residues in human pol betaYun Xiang, Peter Oelschlaeger, Jan Florián, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2013
Biochemical characterization of IMP-30, a metallo-β-lactamase with enhanced activity toward ceftazidimeKevin M Pegg, Eleanor M Liu, Alecander E Lacuran, et al.
Pageof 5